Osimertinib & Chemo Boosts Survival in EGFR Lung Cancer
Osimertinib and Chemotherapy: A New Dawn in Lung Cancer Treatment The landscape of advanced non-small cell lung cancer (NSCLC) is constantly evolving. Recent findings from the COMPEL trial, presented at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer (WCLC), offer a promising new direction for patients with EGFR-mutated … Read more